Oxford Bundibugyo Ebola Vaccine Candidate Receives CEPI Backing Amid Outbreak

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced accelerated development for three investigational vaccines targeting the Bundibugyo ebolavirus, including a candidate from the Oxford Vaccine Group at the University of Oxford. This urgent action comes in response to a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighboring Uganda, underscoring the need for strengthened public health responses and medical countermeasures.